| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Revenue | $2.81B | — |
| Cost of Revenue | $593.3M | — |
| Gross Profit | $2.22B | — |
| R&D Expense | $540.3M | — |
| SG&A Expense | $263.4M | — |
| Operating Income | $472.6M | — |
| Pre-tax Income | $486.0M | — |
| Income Tax | $91.0M | — |
| Net Income | $394.9M | — |
| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $797.2M | +39.1% |
| Short-term Investments | $6.2M | -97.5% |
| Accounts Receivable | $454.8M | +34.3% |
| Inventory | $35.9M | +15.9% |
| Current Assets | $1.85B | +31.2% |
| Total Assets | $5.25B | +18.2% |
| Current Liabilities | $1.47B | +17.6% |
| Line Item | 2021-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $653.4M | — |
| Capital Expenditures | $54.2M | — |
| Investing Cash Flow | $36.4M | — |
| Financing Cash Flow | -$653.3M | — |
| Free Cash Flow | $599.2M | — |
| EPS (Basic) | $6.59 | — |
| EPS (Diluted) | $6.55 | — |
| Stockholders' Equity |
| $2.80B |
| +40.1% |